Ads
related to: GSK plc- Discover Careers
Discover What Matters Most.
View GSK Opportunities.
- Our People
Watch A Video To Learn About
GSK Thriving Together.
- Purpose & Culture
Learn About GSK, A Global Biopharma
Company With A Purpose.
- GSK Media & Press
Find The Latest Press Releases,
Media Assets, & Media Contacts.
- Behind The Science
Read Articles & Watch Videos
About Innovation Stories At GSK.
- GSK Diversity & Inclusion
Greater Opportunity To Create
Better Health Outcomes.
- Discover Careers
Search results
GSK plc (GSK): Is It the Best FTSE Dividend Stock to Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance Canada· 2 hours agoWe recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are...
Should We Be Delighted With GSK plc's (LON:GSK) ROE Of 36%?
Simply Wall St. via Yahoo Finance Canada· 5 days agoWhile some investors are already well versed in financial metrics (hat tip), this article is for...
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Zacks via Yahoo Finance Canada· 5 days agoGSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration...
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
Zacks via Yahoo Finance Canada· 5 days agoIt was a regular week for the biotech sector with quite a few important pipeline and regulatory...
GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots
Bloomberg· 6 days agoHave a confidential tip for our reporters? GSK Plc agreed to pay as much as €1.4 billion ($1.5...
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
Digital Journal· 6 days agoGSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinationsCureVac receives €400 ...
Gilead (GILD) Loses 17.6% YTD: How Should You Play the Stock?
Zacks via Yahoo Finance Canada· 16 hours agoWhile Gilead (GILD) has been reeling under pressure year to date due to pipeline setbacks, holding...
US inks vaccine deal with Moderna as bird flu threat looms
Detroit News· 7 days agoModerna Inc. secured nearly $200 million from the US government to speed development of an mRNA...
Increasing Demand Customized Treatment is likely to Boost Necrotizing Fasciitis Treatment Market...
Digital Journal· 6 days agoNecrotizing Fasciitis Treatment Industry is Expected to Reach USD 4.5 Billion by 2034 And Grow at A CAGR of 5.2%. NEWARK, DE / ACCESSWIRE / July 3, 2024 / The necrotizing fasciitis treatment ...
Bioz Brings Cutting-Edge AI Citation Widgets to Precision X-Ray, Inc.'s Product Pages
Digital Journal· 6 days ago...Cultural Series Redefines AI & Visual Art in Mykonos & Bodrum GSK and CureVac to Restructure Collaboration into New Licensing Agreement...Value mRNA Pipeline Opportunities InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 3 'Port of Hueneme Cares...
Ad
related to: GSK plc